Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00189358
Status:
COMPLETED
Last Update Posted:
2010-07-20
First Post:
2005-09-12
Brief Title:
A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy
Sponsor:
AGO Study Group
Organization:
AGO Study Group
Organization Data
Organization:
AGO Study Group
Class:
OTHER
Study ID:
AGO-OVAR 26
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AGO Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None